Steven Lucio leads the spend management Insights and Intelligence team, which provides Vizient members, suppliers, and the health care community with clinical and industry-related resources. Steven and the team include trained clinicians (pharmacists and other subject matter experts) representing expertise in a wide range of clinical and operational disciplines related to oncology care, specialty pharmacy, regulatory compliance, market research, supply chain, the payor landscape, acute care, medication safety and evidence-based medicine. From the impact of the Inflation Reduction Act to the efforts to end drugs shortages to the expansion of gene therapies and other pipeline developments, Steven and this team apply their knowledge to maintaining a pulse on clinical, market and legislative developments, and forecast trends and potential impact to the Vizient community.
Steven supports Vizient’s advocacy and public policy initiatives. He has provided insights on topics including essential medications, drug shortages, white-bagging, the Unapproved Drug Initiative and 340B strategies. In addition, he represents Vizient at legislative listening sessions, FDA briefings and other policy-making and stakeholder engagement opportunities.
Steven holds a doctorate in pharmacy from Creighton University and a bachelor’s degree in pharmacy from the University of Texas at Austin, and is a board-certified pharmacotherapy specialist.